Determination of the enantiomer of a cholesterol-lowering drug by cyclodextrin-modified micellar electrokinetic chromatography.

Noroski, J E; Mayo, D J; Moran, M

Noroski, J E; Mayo, D J; Moran, M.

Affiliation

Noroski JE; Bristol-Myers Squibb Pharmaceutical Research Institute, New Brunswick, NJ 08903-0191, USA.

J Pharm Biomed Anal ; 13(1): 45-52, 1995 Jan.

Article in En | MEDLINE | ID: mdl-7718633

Subject(s)

Anticholesteremic Agents/analysis; Cyclodextrins; Fluorobenzenes/analysis; Tetrazoles/analysis; beta-Cyclodextrins; 2-Hydroxypropyl-beta-cyclodextrin; Anticholesteremic Agents/chemistry; Anticholesteremic Agents/isolation & purification; Chromatography/methods; Electrophoresis/methods; Fluorobenzenes/chemistry; Fluorobenzenes/isolation & purification; Micelles; Reproducibility of Results; Stereoisomerism; Tetrazoles/chemistry; Tetrazoles/isolation & purification

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Cyclodextrins / Beta-Cyclodextrins / Fluorobenzenes / Anticholesteremic Agents Language: En Journal: J Pharm Biomed Anal Year: 1995 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links